|
DLAT expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.84509999968353E-07 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.64029999999827E-05 |
| Normal-vs-Stage2 |
5.511000E-01 |
| Normal-vs-Stage3 |
8.87250000136675E-08 |
| Normal-vs-Stage4 |
4.33589997239636E-09 |
| Stage1-vs-Stage2 |
3.618000E-02 |
| Stage1-vs-Stage3 |
4.822300E-02 |
| Stage1-vs-Stage4 |
6.782500E-03 |
| Stage2-vs-Stage3 |
3.203500E-03 |
| Stage2-vs-Stage4 |
4.025500E-04 |
| Stage3-vs-Stage4 |
2.391400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.45669999951359E-07 |
| Normal-vs-AfricanAmerican |
3.879800E-03 |
| Normal-vs-Asian |
4.415600E-04 |
| Caucasian-vs-AfricanAmerican |
6.300800E-01 |
| Caucasian-vs-Asian |
7.316400E-01 |
| AfricanAmerican-vs-Asian |
8.590200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.52469999964633E-07 |
| Normal-vs-Female |
8.25970000000176E-05 |
| Male-vs-Female |
8.806200E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.55200000000156E-05 |
| Normal-vs-Age(41-60Yrs) |
8.73550000002332E-07 |
| Normal-vs-Age(61-80Yrs) |
7.155800E-04 |
| Normal-vs-Age(81-100Yrs) |
8.679900E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.720970E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.965600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.057800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.820000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.915800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.480200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.179000E-01 |
| Classical-VS-Follicular |
3.387800E-02 |
| Classical-VS-Other |
5.685200E-01 |
| Classical-VS-Normal |
9.41000000032055E-07 |
| Tall-VS-Follicular |
2.418400E-02 |
| Tall-VS-Other |
7.845800E-01 |
| Tall-VS-Normal |
5.7085999999984E-05 |
| Follicular-VS-Other |
3.003000E-01 |
| Follicular-VS-Normal |
8.479800E-02 |
| Other-VS-Normal |
1.088210E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.64089999996364E-06 |
| Normal-vs-N1 |
1.01409999953006E-07 |
| N0-vs-N1 |
3.966400E-02 |
|
|
